Trust Company of the South’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.03M Sell
862
-305
-26% -$312K 0.15% 54
2026
Q1
$1.07M Buy
1,167
+371
+47% +$376K 0.17% 52
2025
Q4
$855K Sell
796
-290
-27% -$277K 0.14% 56
2025
Q3
$829K Buy
1,086
+191
+21% +$142K 0.14% 56
2025
Q2
$698K Hold
895
0.12% 62
2025
Q1
$739K Buy
895
+275
+44% +$229K 0.15% 58
2024
Q4
$479K Hold
620
0.1% 74
2024
Q3
$549K Hold
620
0.12% 69
2024
Q2
$561K Hold
620
0.13% 67
2024
Q1
$482K Sell
620
-205
-25% -$146K 0.11% 73
2023
Q4
$480K Buy
+825
New +$482K 0.13% 66

Other funds holding LLY

Trust Company of the South's LLY Position: Q2 2026 in Review

Trust Company of the South reduced its Eli Lilly (LLY) stake by 26% in Q2 2026, selling an estimated $312K and leaving 862 shares worth $1.03M. The position accounts for 0.15% of the portfolio, ranked #54.

Trust Company of the South first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.07M in Q1 2026. 3,039 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Trust Company of the South held 862 shares of Eli Lilly worth $1.03M as of Q2 2026.
  • Trust Company of the South sold 305 Eli Lilly shares in Q2 2026, an estimated $312K.
  • Eli Lilly made up 0.15% of Trust Company of the South's portfolio in Q2 2026, its #54 holding.
  • Trust Company of the South first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • Trust Company of the South's Eli Lilly position peaked at $1.07M in Q1 2026.
  • 3,039 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Trust Company of the South's 13F filing for Q2 2026, filed 1 Jul 2026.